sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Long-Acting Monoclonal Antibodies Market Size study, by Source Type (Murine, Chimeric, Humanized, Human) by Indication (Cancer, Autoimmune Disease, inflammatory Disease, Infectious Disease, others) by End User (Hospitals Pharmacies, Drugs Stores, Retail Pharmacies, E- Commerce) and Regional Forecasts 2021-2027

Global Long-Acting Monoclonal Antibodies Market Size study, by Source Type...

Home / Categories / Healthcare
Global Long-Acting Monoclonal Antibodies Market Size study, by Source Type (Murine, Chimeric, Humanized, Human) by Indication (Cancer, Autoimmune Disease, inflammatory Disease, Infectious Disease, others) by End User (Hospitals Pharmacies, Drugs Stores, Retail Pharmacies, E- Commerce) and Regional Forecasts 2021-2027
Global Long-Acting Monoclonal Antibodies Market...
Report Code
RO1/103/1875

Publish Date
11/Jan/2022

Pages
214
PRICE
$ 4250/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 4950/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 5650/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. 1.2.1. Long-Acting Monoclonal Antibodies Market, by Region, 2019-2027 (USD Billion)
1.2.2. 1.2.1. Long-Acting Monoclonal Antibodies Market, by Source Type, 2019-2027 (USD Billion)
1.2.3. 1.2.1. Long-Acting Monoclonal Antibodies Market, by Indication, 2019-2027 (USD Billion)
1.2.4. 1.2.1. Long-Acting Monoclonal Antibodies Market, by End User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global 1.2.1. Long-Acting Monoclonal Antibodies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global 1.2.1. Long-Acting Monoclonal Antibodies Market Dynamics
3.1. 1.2.1. Long-Acting Monoclonal Antibodies Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing therapeutic monoclonal antibody market
3.1.1.2. Current Pandemic situation of Covid-19
3.1.2. Market Challenges
3.1.2.1. High Manufacturing cost
3.1.3. Market Opportunities
3.1.3.1. Rapid growth of chronic diseases
Chapter 4. Global 1.2.1. Long-Acting Monoclonal Antibodies Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, by Source Type
6.1. Market Snapshot
6.2. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by Source Type, Performance - Potential Analysis
6.3. Global 1.2.1. Long-Acting Monoclonal Antibodies Market Estimates & Forecasts by Source Type 2018-2027 (USD Billion)
6.4. 1.2.1. Long-Acting Monoclonal Antibodies Market, Sub Segment Analysis
6.4.1. Murine
6.4.2. Chimeric
6.4.3. Humanized
6.4.4. Human

Chapter 7. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, by Indication
7.1. Market Snapshot
7.2. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by Indication, Performance - Potential Analysis
7.3. Global 1.2.1. Long-Acting Monoclonal Antibodies Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
7.4. 1.2.1. Long-Acting Monoclonal Antibodies Market, Sub Segment Analysis
7.4.1. Cancer
7.4.2. Autoimmune Diseases
7.4.3. Inflammatory Diseases
7.4.4. Infectious Diseases
7.4.5. Others

Chapter 8. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, by End User
8.1. Market Snapshot
8.2. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by End User, Performance - Potential Analysis
8.3. Global 1.2.1. Long-Acting Monoclonal Antibodies Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
8.4. 1.2.1. Long-Acting Monoclonal Antibodies Market, Sub Segment Analysis
8.4.1. Hospitals Pharmacies
8.4.2. Drug Stores
8.4.3. Retail Pharmacies
8.4.4. E-commerce


Chapter 9. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, Regional Analysis
9.1. 1.2.1. Long-Acting Monoclonal Antibodies Market, Regional Market Snapshot
9.2. North America 1.2.1. Long-Acting Monoclonal Antibodies Market
9.2.1. U.S. 1.2.1. Long-Acting Monoclonal Antibodies Market
9.2.1.1. Source Type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Indication breakdown estimates & forecasts, 2018-2027
9.2.1.3. End User breakdown estimates & forecasts, 2018-2027

9.2.2. Canada 1.2.1. Long-Acting Monoclonal Antibodies Market
9.3. Europe 1.2.1. Long-Acting Monoclonal Antibodies Market Snapshot
9.3.1. U.K. 1.2.1. Long-Acting Monoclonal Antibodies Market
9.3.2. Germany 1.2.1. Long-Acting Monoclonal Antibodies Market
9.3.3. France 1.2.1. Long-Acting Monoclonal Antibodies Market
9.3.4. Spain 1.2.1. Long-Acting Monoclonal Antibodies Market
9.3.5. Italy 1.2.1. Long-Acting Monoclonal Antibodies Market
9.3.6. Rest of Europe 1.2.1. Long-Acting Monoclonal Antibodies Market
9.4. Asia-Pacific 1.2.1. Long-Acting Monoclonal Antibodies Market Snapshot
9.4.1. China 1.2.1. Long-Acting Monoclonal Antibodies Market
9.4.2. India 1.2.1. Long-Acting Monoclonal Antibodies Market
9.4.3. Japan 1.2.1. Long-Acting Monoclonal Antibodies Market
9.4.4. Australia 1.2.1. Long-Acting Monoclonal Antibodies Market
9.4.5. South Korea 1.2.1. Long-Acting Monoclonal Antibodies Market
9.4.6. Rest of Asia Pacific 1.2.1. Long-Acting Monoclonal Antibodies Market
9.5. Latin America 1.2.1. Long-Acting Monoclonal Antibodies Market Snapshot
9.5.1. Brazil 1.2.1. Long-Acting Monoclonal Antibodies Market
9.5.2. Mexico 1.2.1. Long-Acting Monoclonal Antibodies Market
9.6. Rest of The World 1.2.1. Long-Acting Monoclonal Antibodies Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Eli Lilly
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbott Laboratories
10.2.3. AstraZeneca plc
10.2.4. Amgen Inc.
10.2.5. Bayer AG
10.2.6. Johnson & Johnson
10.2.7. Pfizer
10.2.8. GlaxoSmithKline Plc.
10.2.9. Merck & Co. Inc.
10.2.10. Novartis











10.2.11. Research Process
10.3. Research Process
10.3.1. Data Mining
10.3.2. Analysis
10.3.3. Market Estimation
10.3.4. Validation
10.3.5. Publishing
10.4. Research Attributes
10.5. Research Assumption

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com